2269:HKG
WuXi Biologics (Cayman) Inc
၄၈.၂၀ HK$
arrow_downward
-၀.၉၀%(-၀.၄၄) 1D
အောက် ၁၆, GMT+၈ ၁၆:၀၈:၁၄ · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2269...
Open
၄၉.၉၈ HK$
High
၅၀.၈၅ HK$
Low
၄၅.၈၂ HK$
Mkt. cap
ဋေ ၁.၉၈ သ
Avg. vol.
၃.၀၄ ကုဋေ
Volume
၅.၅၂ ကုဋေ
P/E ratio
၃၄.၄၈
52-wk high
၅၈.၀၀ HK$
52-wk low
၂၈.၄၈ HK$
EPS
၁.၄၀ HK$
Shares outstanding
၁၂၂.၅၂ ဋေ
No. of employees
၁ သောင်း
Open
၄၉.၉၈ HK$
High
၅၀.၈၅ HK$
Low
၄၅.၈၂ HK$
Mkt. cap
ဋေ ၁.၉၈ သ
Avg. vol.
၃.၀၄ ကုဋေ
Volume
၅.၅၂ ကုဋေ
P/E ratio
၃၄.၄၈
52-wk high
၅၈.၀၀ HK$
52-wk low
၂၈.၄၈ HK$
EPS
၁.၄၀ HK$
Shares outstanding
၁၂၂.၅၂ ဋေ
No. of employees
၁ သောင်း
News stories
From web sources and news partners
GlobeNewswire
·
ပြီးခဲ့သည့် ၅၇ မိနစ်
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
WKZO
·
ပြီးခဲ့သည့် ၁ မိနစ်
Asian stocks skid, Wall Street and bonds aided by oil slip
marketscreener.com
·
ပြီးခဲ့သည့် ၂၁ မိနစ်
CECO Environmental Corp. Primary Exchange Listing will Change to Texas Stock Exchange from Nasdaq Global Select
Bloomberg.com
·
ပြီးခဲ့သည့် ၂ နာရီ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
About WuXi Biologics (Cayman) Inc